Mechanisms of microvascular endothelial cell injury caused by extracellular histones

Information

  • Research Project
  • 10294004
  • ApplicationId
    10294004
  • Core Project Number
    R01HL155051
  • Full Project Number
    1R01HL155051-01A1
  • Serial Number
    155051
  • FOA Number
    PA-20-185
  • Sub Project Id
  • Project Start Date
    9/1/2021 - 4 years ago
  • Project End Date
    7/31/2025 - 3 months ago
  • Program Officer Name
    ZHOU, GUOFEI
  • Budget Start Date
    9/1/2021 - 4 years ago
  • Budget End Date
    7/31/2022 - 3 years ago
  • Fiscal Year
    2021
  • Support Year
    01
  • Suffix
    A1
  • Award Notice Date
    9/1/2021 - 4 years ago

Mechanisms of microvascular endothelial cell injury caused by extracellular histones

Mechanisms of microvascular endothelial cell injury caused by extracellular histones Abstract Despite the recent progress towards understanding of the basis of increased vascular permeability and inflammation caused by circulating vasoactive peptides, lipids, and exogenous agents (bacteria, toxins, particulate matter), the impact of intracellular compounds released by injured tissues and known as danger- associated molecular patterns (DAMPs) on severity of ongoing acute respiratory syndrome caused by sepsis or traumatic injury remain poorly understood, and molecular mechanisms underlying deleterious effects of DAMPs warrant further investigations. This translational study will investigate effects of nucleus-associated DAMPs, histones, on vascular endothelial function and test a new hypothetical mechanism by which circulating histones target lung microvascular endothelium and worsen lung injury. The central hypothesis tested in this application is that circulating histones elevated during acute lung injury, sepsis, trauma, severe inflammation, or major surgery target vascular endothelium and contribute to overall vascular dysfunction, organ damage and mortality. This may be achieved through: 1) histone-induced engagement of scavenger receptor cluster of differentiation 36 (CD36) leading to propagation of endothelial inflammation and barrier dysfunction; and 2) CD36-induced activation of death signaling by circulating histones contributing to augmentation of ongoing endothelial dysfunction and lung injury. The proposed study may have a broader impact on the other aspects of vascular responses to inflammatory or pro-angiogenic stimuli. Proposed studies will provide mechanistic insights offering better understanding of factors that define severity of sepsis and trauma. These studies may lead to identification of molecular targets and developing new therapeutic approaches to mitigate such deleterious effects of circulating DAMPs.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R01
  • Administering IC
    HL
  • Application Type
    1
  • Direct Cost Amount
    301377
  • Indirect Cost Amount
    164251
  • Total Cost
    465628
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    838
  • Ed Inst. Type
    SCHOOLS OF MEDICINE
  • Funding ICs
    NHLBI:465628\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    IVPP
  • Study Section Name
    Integrative Vascular Physiology and Pathology Study Section
  • Organization Name
    UNIVERSITY OF MARYLAND BALTIMORE
  • Organization Department
    INTERNAL MEDICINE/MEDICINE
  • Organization DUNS
    188435911
  • Organization City
    BALTIMORE
  • Organization State
    MD
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    212011508
  • Organization District
    UNITED STATES